An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A study reveals significant liver health improvements in patients.

Ozempic is effective in treating a severe form of liver disease that affects millions of Americans, according to a study published in The New England Journal of Medicine in April. The research ...

But now, it might be about to earn a new title: a potential game-changer for liver disease. You read that right—Ozempic may not ... health in NASH patients. The study was led by Dr Arun Sanyal ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

The brands Rybelsus and Ozempic are currently FDA-approved ... type of what used to be called nonalcoholic fatty liver disease. This study involved participants from hundreds of clinical sites ...

Semaglutide, sold under brand names like Ozempic, Rybelsus ... is generally well-tolerated by patients with liver disease. The study participants reflected a diverse population of MASH patients.

Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.

Doctors are also seeing success in treating people with certain liver diseases. Isaacs prescribes GLP-1s for people with a ...